Transcend Capital Advisors, LLC Bristol Myers Squibb CO Transaction History

Transcend Capital Advisors, LLC

  • $1.23 Billion
  • Q1 2024

A detailed history of Transcend Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 196,726 shares of BMY stock, worth $8.17 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
196,726
Previous 161,567 21.76%
Holding current value
$8.17 Million
Previous $8.29 Million 28.69%
% of portfolio
0.87%
Previous 0.74%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$47.98 - $54.4 $1.69 Million - $1.91 Million
35,159 Added 21.76%
196,726 $10.7 Million
Q4 2023

Feb 05, 2024
BUY
$48.48 - $57.85 $1.84 Million - $2.19 Million
37,853 Added 30.6%
161,567 $8.29 Million
Q3 2023

Oct 31, 2023
SELL
$57.89 - $64.73 $114,622 - $128,165
-1,980 Reduced 1.58%
123,714 $7.18 Million
Q2 2023

Jul 13, 2023
SELL
$63.71 - $70.74 $218,589 - $242,708
-3,431 Reduced 2.66%
125,694 $8.04 Million
Q1 2023

Apr 12, 2023
BUY
$65.71 - $74.53 $26,152 - $29,662
398 Added 0.31%
129,125 $8.95 Million
Q4 2022

Jan 20, 2023
SELL
$68.48 - $81.09 $241,528 - $286,004
-3,527 Reduced 2.67%
128,727 $0
Q3 2022

Oct 17, 2022
BUY
$0.13 - $76.84 $376 - $222,298
2,893 Added 2.24%
132,254 $9.4 Million
Q2 2022

Jul 12, 2022
SELL
$72.62 - $79.98 $18,953 - $20,874
-261 Reduced 0.2%
129,361 $9.96 Million
Q1 2022

Apr 20, 2022
BUY
$61.48 - $73.72 $82,936 - $99,448
1,349 Added 1.05%
129,622 $9.47 Million
Q4 2021

Jan 20, 2022
SELL
$53.63 - $62.52 $55,453 - $64,645
-1,034 Reduced 0.8%
128,273 $8 Million
Q3 2021

Nov 04, 2021
SELL
$59.17 - $69.31 $1.92 Million - $2.24 Million
-32,387 Reduced 20.03%
129,307 $7.53 Million
Q2 2021

Aug 13, 2021
BUY
$61.91 - $67.42 $56,338 - $61,352
910 Added 0.57%
161,694 $10.8 Million
Q1 2021

May 12, 2021
SELL
$59.34 - $66.74 $190,659 - $214,435
-3,213 Reduced 1.96%
160,784 $10.1 Million
Q4 2020

Feb 12, 2021
SELL
$57.74 - $65.43 $1.55 Million - $1.76 Million
-26,843 Reduced 14.07%
163,997 $10.2 Million
Q3 2020

Nov 13, 2020
SELL
$57.43 - $63.64 $164,766 - $182,583
-2,869 Reduced 1.48%
190,840 $11.5 Million
Q2 2020

Aug 05, 2020
SELL
$54.82 - $64.09 $451,552 - $527,909
-8,237 Reduced 4.08%
193,709 $11.4 Million
Q1 2020

May 08, 2020
SELL
$46.4 - $67.43 $58,696 - $85,298
-1,265 Reduced 0.62%
201,946 $11.3 Million
Q4 2019

Feb 19, 2020
BUY
$49.21 - $64.19 $10 Million - $13 Million
203,211 New
203,211 $13 Million

Others Institutions Holding BMY

# of Institutions
2,554
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email